Could your own cells replace insulin shots? early trial aims to find out

NCT ID NCT07118475

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study tests whether insulin-making cells grown from a patient's own pancreatic tissue can be safely transplanted under the belly skin to reduce or replace insulin shots. Twenty-four adults with insulin-dependent type 2 diabetes will take part. The main goal is safety, but researchers will also check blood sugar control and insulin needs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

autologous islet cells grown from the patient's own pancreatic tissue

What this could lead to

If successful, this could reduce or eliminate the need for daily insulin injections in some people with type 2 diabetes, offering a functional cure.

What could go wrong

This is a very early, small study (24 people) focused on safety. The cells may not work as hoped, and there are risks from the tissue collection procedure and transplant.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS (TYPE 2) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Zhongshan Hospital

    Shanghai, 200032, China